Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

Cost-effectiveness of omalizumab for the treatment of chronic spontaneous urticaria

PaperCitations, authors & open-access status

Cost-effectiveness of omalizumab for the treatment of chronic spontaneous urticaria is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 33 citations, 2018 year and hybrid oa status.

33
Citations
2018
Year
hybrid
OA Status

Related on ScholarIQ

Tim A. Kanters
Author
British Journal of Dermatology
Journal
Urticaria and Related Conditions
Topic
Urticaria and Related Conditions
Topic
Coagulation, Bradykinin, Polyphosphates, and Angioedema
Topic
Mast cells and histamine
Topic
470M+ articles · free account